Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment.

Kraus, Christoph

Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment. [electronic resource] - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 05 2020 - 982-989 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

1740-634X

10.1038/s41386-020-0624-0 doi


Antidepressive Agents--therapeutic use
Brain--diagnostic imaging
Brain Mapping
Depression
Depressive Disorder, Major--diagnostic imaging
Humans
Ketamine--therapeutic use
Magnetic Resonance Imaging